
Gerhard F. Burbach
CEO of Thoratec
Education
- Bachelor’s degree in industrial engineering - Stanford University
- Master’s of business administration - Harvard Business School
Overview
Gerhard F. Burbach is a Former CEO of Thoratec, Inc.(THOR)
Gerhard “Gary” F. Burbach serves on the board of directors for several public and private companies in the medical and life science industry including, Fluidigm, a public company manufacturing and marketing innovative technologies for life sciences research, and Vascular Dynamics, Inc., a private medical device company developing an innovative solution for hypertension. He is also the chairman of the board of directors of both Autonomic Technologies, Inc., a private medical device company developing neurostimulation based therapies, and Procyrion Inc., a private medical device company focused on the treatment of chronic heart failure.
From 2006 to 2014, Mr. Burbach was president, chief executive officer and director of Thoratec Corporation, a company that develops, manufactures and markets proprietary medical devices used for circulatory support. Prior to that, he held executive leadership positions at Digirad Corporation, Philips Medical Systems, and ADAC Laboratories. Mr. Burbach also spent six years at McKinsey & Company, Inc. focused primarily in the firm’s healthcare practice.
Mr. Burbach received a bachelor’s degree in industrial engineering from Stanford University and a master’s of business administration from Harvard Business School.
Career
- Thoratec - CEO